Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Rang în acțiuni #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Preț acțiune
$0.01292666
Ultima sincronizare: 2025-04-08
Capitalizare de piață
$157.54K
Schimbare (1 zi)
6.84%
Schimbare (1 an)
0.00%
Țară
GB
Tranzacționează Synairgen plc (SNG)

Categorie

Istoricul spliturilor pentru Synairgen plc (SNG)
Acțiunea Synairgen plc (simbol: SNG) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 13, 2026.
O acțiune SNG cumpărată înainte de Aug 13, 2026 este echivalentă astăzi cu 0 acțiuni SNG.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE